definiens: means all operating expenses incurred by and in support of all Manufacturing cost center s and quality operations . Overhead includes : • wages for indirect labor, related payroll taxes and employee benefits ; • depreciation on specific assets used to Manufacture the Product or New Collaboration Compound ; • taxes ; • insurance ; • rent ( paid at market rates ) ; • repairs and maintenance ; • supplies, including gowning supplies ; • utilities ; • factory administration expenses ; • other similar cost elements of factory overhead ; • an allocation of general and administrative overhea d and the cost of manufacturing centers and quality operations, which allocation shall be made in a manner consistent with such allocations applied to other products made in the same producti on center with the same technology, and consistent with past practice ; and • an allocation of depreciation on assets being used in the same production center using the same technology, which allocation shall be made in a man ner consistent with such allocations a pplied to other products made in the same production center w ith the same technology, and consistent with past practice . ] The following expenses shall not be included in Man ufacturing Cost • idle capacity ; and • general and administrative costs not associated wit h the production process SCHEDULE 2.3 INITIAL MEMBERS OF THE JEC Reata [ * * * ] [ * * * ] [COMPANY] [ * * * ] [ * * * ] [ * * * ] SCHEDULE 2.4 INITIAL MEMBERS OF THE JRDI Reata [ * * * ] [ * * * ] [ * * * ] [ * * * ] [COMPANY] [ * * * ] [ * * * ] [ * * * ] [ * * * ] SCHEDULE 3.1 DISCOVERY RESEARCH PLAN [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] SCHEDULE 4.3(A ) JOINT EXPLORATORY DEVELOPMENT PLAN 4.3(a)(i ) The plans for characterization of the Lea d Compounds and Development Candidates existing as of the Effective Date are as follows : [ * * * ] Pre - Clinical Assessment of Lead Compounds and Development Candidates [ * * * ] [ * * * ] Title [ * * * ] General Description Responsible Party [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] Title General Description Estimated Start Date Responsible Party [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] [ * * * ] 4.3(a)(ii ) The Initial Indications in which the Par ties intend to conduct Indication Survey Studies ar e as follows : [ * * * ]